Ángel Michael Ortiz Zúñiga

Prof. Ángel Michael Ortiz Zúñiga

Endocrinology, Hospital Vall Hebron, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2017 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
Ramon VilallongaRamon Vilallonga
Ramon Vilallonga
JBJosé M Balibrea
José M Balibrea
ACAnna Curell
Anna Curell
OGOscar Gonzalez
Oscar Gonzalez
ECEnric Caubet
Enric Caubet
JFJosé Manuel Fort
José Manuel Fort

8 January 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
OSOlga Simo-Servat
Olga Simo-Servat
Andreea Ciudin MihaiAndreea Ciudin Mihai
Andreea Ciudin Mihai
Ángel Michael Ortiz ZúñigaÁngel Michael Ortiz Zúñiga
Ángel Michael Ortiz Zúñiga
CHCristina Hernandez
Cristina Hernandez
Rafael SimóRafael Simó
Rafael Simó
Type 2 diabetic (T2D) subjects have a significantly higher risk of developing mild cognitive impairment (MCI) and dementia than age-matched non-diabetic individuals. However, the accurate evaluation of cognitive status is based on complex neuropsychological tests, which makes their incorporation into the current standard of care for the T2D population infeasible. Given that the ability to maintain visual gaze on a single location (fixation) is hampered in Alzheimer’s disease (AD), the aim of the present study was: (1) To assess whether the evaluation of gaze fixation during fundus-driven microperimetry correlated with cognitive status in T2D subjects; (2) to examine whether the addition of fixational parameters to the assessment of retinal sensitivity increased the predictive value of retinal microperimetry in identifying T2D subjects with MCI. For this purpose, fixation parameters and retinal sensitivity were compared in three age-matched groups of T2D subjects: normocognitive (n = 34), MCI (n = 33), and AD (n = 33). Our results showed that fixation is significantly more unstable in MCI subjects than normocognitive subjects, and even more altered in those affected by AD (ANOVA; p < 0.01). Moreover, adding fixation parameters to retinal sensitivity significantly increases the predictive value in identifying those subjects with MCI: ROC (Receiver Operating Characteristic) Area 0.68 with retinal sensitivity alone vs. ROC Area 0.86 when parameters of fixation are added to retinal sensitivity (p < 0.01). In conclusion, our results suggest that fixational eye movement parameters assessed by fundus-microperimetry represent a new tool for identifying T2D subjects at risk of dementia.

Verified
Journal Article
Open access
PDF file
Andreea Ciudin MihaiAndreea Ciudin Mihai
Andreea Ciudin Mihai
EFEnzamaria Fidilio
Enzamaria Fidilio
Ángel Michael Ortiz ZúñigaÁngel Michael Ortiz Zúñiga
Ángel Michael Ortiz Zúñiga
SPSara Pich
Sara Pich
ESEduardo Salas
Eduardo Salas
Rafael SimóRafael Simó
Rafael Simó
Introduction: The aim of this pilot study was to assess genetic predisposition risk scores (GPS) in type 2 diabetic and non-diabetic patients in order to predict the better response to bariatric surgery (BS) in terms of either weight loss or diabetes remission. Research Design and Methods: A case-control study in which 96 females (47 with type 2 diabetes) underwent Roux-en-Y gastric by-pass were included. The DNA was extracted from saliva samples and SNPs were examined and grouped into 3 GPS. ROC curves were used to calculate sensitivity and specificity. Results: A highly sensitive and specific predictive model of response to BS was obtained by combining the GPS in non-diabetic subjects. This combination was different in diabetic subjects and highly predictive of diabetes remission. Additionally, the model was able to predict the weight regain and type 2 diabetes relapse after 5 years’ follow-up. Conclusions: Genetic testing is a simple, reliable and useful tool for implementing personalized medicine in type 2 diabetic patients requiring BS.

24 May 2023 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
JAJudit Amigó
Judit Amigó
Ángel Michael Ortiz ZúñigaÁngel Michael Ortiz Zúñiga
Ángel Michael Ortiz Zúñiga
AUAna M. Ortiz de Urbina
Ana M. Ortiz de Urbina
MSMònica Sánchez
Mònica Sánchez
MDMarcos Dos-Santos
Marcos Dos-Santos
OSOlga Simo-Servat
Olga Simo-Servat

1 September 2022 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
Ángel Michael Ortiz ZúñigaÁngel Michael Ortiz Zúñiga
Ángel Michael Ortiz Zúñiga
PFPilar Costa Forner
Pilar Costa Forner
ATArturo Cirera de Tudela
Arturo Cirera de Tudela
ARAmador Garcia Ruiz
Amador Garcia Ruiz
MMMarta Comas Martinez
Marta Comas Martinez
Andreea Ciudin MihaiAndreea Ciudin Mihai
Andreea Ciudin Mihai
Introduction: Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) is a recent bariatric surgery technique, highly effective in terms of weight loss. Nevertheless, data regarding the impact of SADI-S at mid-long term (after >5 years of follow-up) are scarce. Objectives: To evaluate the effect of lengths of common intestinal loop on the evolution of patients with morbid obesity (MO), who undergo SADI-S. Materials and Methods: Descriptive study (case series), including patients with MO who underwent SADI-S procedure between January 2012 and December 2015 with at least 5 years of follow-up. Patients were classified as “Old-SADI-S” (OS) when length of the common alimentary loop was 2.5 m. Clinical parameters and nutritional parameters were included. Results: Twenty-nine cases were included (17 OS; 12 NS), 86.2% women and mean age 46.7 ± 1 years. After 12 months, OS had significantly lower body mass index (29.7 ± 4.8 kg/m2 versus 32.0 ± 5.1 kg/m2, P = .01), without significant differences in the resolution of comorbidities. Nevertheless, OS group had severe malabsorptive complications requiring surgical conversion of OS to NS in 7 patients after 8 months. At 5 years of follow-up, no significant difference was seen between the two groups and resolution of comorbidities was maintained during this period of time. Conclusions: SADI-S is effective in terms of weight loss and resolution of comorbidities at 5 years of follow-up, regardless of the length of the common intestinal loop. However, a common intestinal loop <2.5 m was associated with severe malabsorptive complications that determined the surgical re-conversion in all cases.

25 May 2021 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
APAlejandra Planas
Alejandra Planas
OSOlga Simó-Servat
Olga Simó-Servat
JBJordi Bañeras
Jordi Bañeras
MSMónica Sánchez
Mónica Sánchez
EGEsther García
Esther García
Rafael SimóRafael Simó
Rafael Simó